All Insiders Activity for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)
|
|
|
|
|
After Hours:
$ 0.2499
|
0.0002 (+0.08%)
|
Volume: 17.58k
|
7:32 PM EDT 21-Aug-2019
|
|
|
|
|
|
| Date |
Name: |
Shares |
Transaction |
Value
|
|
|
03/05/19
|
Mark S. Berger,
Chief Medical Officer
|
3,500
|
Option Exercise
at $0.60 per share.
|
$2,100
|
|
02/21/19
|
Sandesh Seth,
|
8,125
|
Option Exercise
at $0.60 per share.
|
$4,875
|
|
12/10/18
|
Steven O'Loughlin,
VP, Finance and Corporate Dev.
|
10,000
|
Buy
at $0.435 per share.
|
$4,350
|
|
12/10/18
|
Sandesh Seth,
|
10,000
|
Buy
at $0.4372 per share.
|
$4,372
|
|
11/19/18
|
Dale L. Ludwig,
Chief Scientific Officer
|
10,000
|
Buy
at $0.4499 per share.
|
$4,499
|
|
07/17/18
|
Sandesh Seth,
|
10,000
|
Buy
at $0.79 per share.
|
$7,900
|
|
07/13/18
|
Richard I. Steinhart,
|
75,000
|
Acqusition
at $0.783 per share.
|
$58,725
|
|
07/13/18
|
Mark S. Berger,
Chief Medical Officer
|
250,000
|
Acqusition
at $0.783 per share.
|
$195,750
|
|
07/13/18
|
Sandesh Seth,
|
1,000,000
|
Acqusition
at $0.783 per share.
|
$783,000
|
|
07/13/18
|
Ajit S. Shetty,
|
75,000
|
Acqusition
at $0.783 per share.
|
$58,725
|
|
07/13/18
|
Nitya G. Ray,
Executive Vice President
|
75,000
|
Acqusition
at $0.783 per share.
|
$58,725
|
|
07/13/18
|
Steven O'Loughlin,
VP, Finance and Corporate Dev.
|
265,000
|
Acqusition
at $0.783 per share.
|
$207,495
|
|
07/13/18
|
C. David Nicholson,
|
75,000
|
Acqusition
at $0.783 per share.
|
$58,725
|
|
07/13/18
|
Jeffrey W. Chell,
|
75,000
|
Acqusition
at $0.783 per share.
|
$58,725
|
|
06/15/18
|
Steven O'Loughlin,
VP, Finance and Corporate Dev.
|
12,000
|
Buy
at $0.50 per share.
|
$6,000
|
|
|
|
|
|
|
|
|